2016-06-23T13:48:58-05:00 2015-12-31 541029635 THOMPSON GREENSPON 4035 RIDGE TOP RD SUITE 700 FAIRFAX VA 22030 990 2015-01-01 131772100 NATIONAL PHARMACEUTICAL COUNCIL INC NATI 2028272100 1717 PENNSYLVANIA AVE NW NO 800 WASHINGTON DC 20006 KATHRYN GLEASON VICE PRESIDENT 2028272100 2016-06-09 1 CHARLES F HELME III CPA P00118452 7033858888 2015 2016-09-27 15:27:22Z KATHRYN GLEASON 1717 PENNSYLVANIA AVE NW NO 800 WASHINGTON DC 20006 15129793 0 X SEE SCHEDULE O X 1953 NY THE NATIONAL PHARMACEUTICAL COUNCIL (NPC) FOCUSES ON RESEARCH DEVELOPMENT, INFORMATION DISSEMINATION, EDUCATION AND COMMUNICATION OF THE CRITICAL ISSUES OF EVIDENCE, INNOVATION AND THE VALUE OF MEDICINES FOR PATIENTS. 20 20 16 0 0 0 0 0 8400000 8186800 546525 360879 0 0 8946525 8547679 0 0 0 0 5377452 4396973 0 0 0 4958245 4021351 10335697 8418324 -1389172 129355 19682661 19206890 7275749 7042865 12406912 12164025 TO SPONSOR, PARTICIPATE IN AND PROMOTE THE SCIENTIFIC ANALYSES OF THE APPROPRIATE USE OF PHARMACEUTICALS AND THE CLINICAL AND ECONOMIC VALUE OF IMPROVED HEALTH OUTCOMES THROUGH PHARMACEUTICAL INNOVATION. 0 0 THE NATIONAL PHARMACEUTICAL COUNCIL SPONSORS AND CONDUCTS SCIENTIFIC ANALYSES OF THE APPROPRIATE USE OF PHARMACEUTICALS AND THE CLINICAL AND ECONOMIC VALUE OF INNOVATION. THE ORGANIZATION'S STRATEGIC FOCUS IS ON EVIDENCE-BASED MEDICINE (EBM) FOR HEALTH CARE DECISION-MAKING TO ENSURE THAT PATIENTS HAVE ACCESS TO HIGH-QUALITY CARE. ALL ACTIVITIES UNDERTAKEN BY THE COUNCIL RELATE TO THESE FUNCTIONS. 0 0 0 1 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 18 0 1 16 1 0 0 0 0 1 1 0 X 20 20 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 X NATIONAL PHARMACEUTICAL COUNCIL 2028272100 1717 PENNSYLVANIA AVE NW NO 800 WASHINGTON DC 20006 DANIEL LEONARD PRESIDENT 40.00 X X 1166223 0 19815 ROBERT DUBOIS VICE PRESIDENT 40.00 X X 457087 0 16769 JOSH OFMAN VICE CHAIRMAN 1.00 X 0 0 0 JEFF STEWART TREASURER 1.00 X 0 0 0 PATRICK MAGRI CHAIRMAN 5.00 X 0 0 0 DAVE TANG DIRECTOR 1.00 X 0 0 0 JEFFREY BLOSS DIRECTOR 1.00 X 0 0 0 GREGORY KEENAN DIRECTOR 1.00 X 0 0 0 DAVID W MILLER DIRECTOR 1.00 X 0 0 0 JEFF HUTH DIRECTOR 1.00 X 0 0 0 MURDO GORDON DIRECTOR 1.00 X 0 0 0 RICHARD H BAGGER DIRECTOR 1.00 X 0 0 0 DAVID J MARTIN DIRECTOR 1.00 X 0 0 0 MARK J NAGY DIRECTOR 1.00 X 0 0 0 MYRIAM MENDILA DIRECTOR 1.00 X 0 0 0 DAVID GOLLAHER DIRECTOR 1.00 X 0 0 0 BLASINE PENKOWSKI DIRECTOR 1.00 X 0 0 0 DEAN HAKANSON DIRECTOR 1.00 X 0 0 0 STEVEN J ROMANO DIRECTOR 1.00 X 0 0 0 MIKE MCCLELLAN DIRECTOR 1.00 X 0 0 0 MIKE DERKACZ DIRECTOR 1.00 X 0 0 0 KATHRYN GLEASON SECRETARY 40.00 X X 194322 0 6627 DON SAWYER DIRECTOR 1.00 X 0 0 0 JENNIFER GRAFF VP, COMPARATIVE EFFECTIVENESS RESEARCH 40.00 X 230802 0 13025 ANDREA HOFELICH VP, COMMUNICATIONS 40.00 X 196702 0 17974 KIMBERLY WESTRICH VP, HEALTH SERVICES RESEARCH 40.00 X 226309 0 15141 MELISSA BAULKWILL DIRECTOR OF ADMINISTRATION 40.00 X 103789 0 19196 MICHAEL CIARAMETARO DIRECTOR OF RESEARCH 40.00 X 181722 0 15489 2756956 0 124036 8 0 1 0 1717 PENNYSYLVANIA AVE LP PO BOX 759431 BALTIMORE MD 21275 RENT 338610 ANALYSIS GROUP INC 111 HUNTINGTON AVE 10TH FLOOR BOSTON MA 02199 RESEARCH/CONSULTING 320079 CONVINGTON & BURLING ONE CITY CENTER 850 10TH ST NW WASHINGTON DC 20001 LEGAL EXPENSES 220805 PRECISION HEALTH ECONOMICS 11100 SANTA MONICA BLVD SUITE 50 LOS ANGELES CA 90025 RESEARCH/CONSULTING 213495 SOCIAL & SCIENTIFIC SYSTEMS INC 8757 GEORGIA AVE 12TH FLOOR SILVER SPRING MD 20910 RESEARCH/CONSULTING 121952 5 MEMBERSHIP DUES 900099 8137500 8137500 PROGRAM INCOME 900099 49300 49300 8186800 229280 229280 6713713 6582114 131599 131599 131599 8547679 8186800 0 360879 2808614 432887 154159 874904 126409 170524 60863 46172 638786 100696 246166 394761 73466 103379 81864 24667 PROGRAMS, SPECIAL STUDI 2066009 ENTERTAINMENT 7800 SUBSCRIPTIONS & MEMBERS 6198 8418324 176199 228802 5123944 4018432 140 0 291304 218213 704035 356827 423733 347208 13599341 14326235 68000 68000 19682661 19206890 676556 806686 3087500 2450000 3511693 3786179 7275749 7042865 X 12406912 12164025 12406912 12164025 19682661 19206890 129355 -372242 0 X X 0 1 X 1 0 1 1 0 589879 300319 289560 114156 56508 57648 347208 PENSION COST LIABILITY 2434169 NONQUALIFIED, DEFERRED COMPENSATION LIABILITY 1084081 DEFERRED LEASE INCENTIVE, NET 267929 3786179 X 8175437 -372242 -372242 8547679 0 8547679 8418324 0 8418324 0 8418324 PART X, LINE 2: PART X, LINE 2: AS OF DECEMBER 31,2015 AND 2014, THE COUNCIL HAS NO UNCERTAIN TAX POSITIONS THAT QUALIFY FOR EITHER RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS AND NO INTEREST AND PENALTIES HAVE BEEN RECORDED IN THE ACCOMPANYING FINANCIAL STATEMENTS RELATED TO UNCERTAIN TAX POSITIONS. X 1 1 X X X 0 1 0 DANIEL LEONARD PRESIDENT 621477 0 291766 0 252980 0 0 0 19815 0 1186038 0 0 0 ROBERT DUBOIS VICE PRESIDENT 406023 0 49440 0 1624 0 0 0 16769 0 473856 0 0 0 KATHRYN GLEASON SECRETARY 171846 0 21000 0 1476 0 0 0 6627 0 200949 0 0 0 JENNIFER GRAFF VP, COMPARATIVE EFFECTIVENESS RESEAR 200447 0 25191 0 5164 0 0 0 13025 0 243827 0 0 0 ANDREA HOFELICH VP, COMMUNICATIONS 170686 0 21000 0 5016 0 0 0 17974 0 214676 0 0 0 KIMBERLY WESTRICH VP, HEALTH SERVICES RESEARCH 199494 0 25191 0 1624 0 0 0 15141 0 241450 0 0 0 MICHAEL CIARAMETARO DIRECTOR OF RESEARCH 160530 0 19776 0 1416 0 0 0 15489 0 197211 0 0 0 PART I, LINE 1A DANIEL LEONARD RECEIVES GROSS-UP PAYMENTS TO THE NONQUALIFIED RETIREMENT PLAN AVAILABLE TO OFFICERS. THESE PAYMENTS ARE INCLUDED IN THEIR TAXABLE COMPENSATION WHEN PAID. PART I, LINE 4B SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN - DANIEL LEONARD-$247,816 FORM 990, PART VI, SECTION B, LINE 11 THE FORM 990 IS REVIEWED BY THE TREASURER AND THE VICE PRESIDENT OF MEMBERSHIP AND OPERATIONS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY COVERS ALL MEMBERS OF THE BOARD, THE OFFICERS AND STAFF AND IS MONITORED BY ANNUAL WRITTEN INFORMATION QUESTIONAIRES FROM THE PRESIDENT WHICH ARE REVIEWED AND MAINTAINED BY THE VICE PRESIDENT OF BUSINESS OPERATIONS AND EXTERNAL AFFAIRS. THE BOARD OFFICERS REVIEW EACH TRANSACTION TO COME BEFORE THE BOARD FOR POTENTIAL OR ACTUAL CONFLICTS OF INTEREST. IF ANY POTENTIAL OR ACTUAL CONFLICTS ARE INDENTIFIED, THE PERSON DETERMINED TO HAVE A CONFLICT IS RECUSED FROM DELIBERATIONS, VOTING OR ANY ACTIONS RELATED TO THE MATTER. THE IDENTIFIED CONFLICTS WOULD BE DOCUMENTED IN THE MINUTES OF EACH BOARD OR COMMITTEE MEETING. FORM 990, PART VI, SECTION B, LINE 15 THE PROCESS FOR DETERMINING COMPENSATION OF THE FOLLOWING PERSONS INCLUDES A REVIEW AND APPROVAL BY THE CHAIRMAN OF THE BOARD, WHO IS AN INDEPENDENT BOARD MEMBER ELECTED ANNUALLY ON A ROTATING BASIS. COMPARABILITY DATA USED IN THE REVIEW PROCESS IS OBTAINED FROM PUBLIC SOURCES, RECRUITERS, AND OTHER HUMAN RESOURCES PROFESSIONALS. THE AUDIT AND BUDGET COMMITTEE APPROVES TOTAL SALARIES AS APPROVED BY THE CHAIRMAN. THE COMPENSATION DETERMINATION PROCESS APPLES TO THE FOLLOWING OFFICE/POSITION AND THE MOST RECENT YEAR FOR WHICH THE PROCESS WAS UNDERTAKEN FOR EACH IS IDENTIFIED. THE CHAIRMAN OF THE BOARD REVIEWS AND APPROVES THE SALARY FOR THE PRESIDENT. THE PRESIDENT REVIEWS AND APPROVES ALL OTHERS WITHIN THE BUDGET APPROVED BY THE AUDIT AND BUDGET COMMITTEES. ALL SALARIES WERE REVIEWED AND APPROVED IN 2014. FORM 990, PART VI, SECTION C, LINE 19 THE NATIONAL PHARMACEUTICAL COUNCIL DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. FORM 990, PART XII, LINE 2C PROCESS HAS NOT CHANGED. FORM 990, PAGE ONE, HEADING J, WEBSITES: WWW.RXROI.ORG WWW.NPCNOW.ORG WWW.YOURPHARMACYBENEFIT.ORG